Mira Pharmaceuticals Inc.
07/08/2025 | Press release | Distributed by Public on 07/08/2025 15:25
Material Event (Form 8-K)
| Item 8.01. | Other Events. |
On July 3, 2025, MIRA Pharmaceuticals, Inc. (the "Company"), sold a total of 1,550,741 shares of its common stock, par value $0.001, in block sales to an institutional investor, at an average price of $1.2981 share (a premium to the prior days close), through its at-the-market equity offering facility (the "Offering"). Gross proceeds from the Offering totalled approximately $2.0 million, prior to deducting fees and expenses. The trades for the Offering were facilitated through Rodman & Renshaw, via the StockBlock platform. The Offering did not include any warrants.
Mira Pharmaceuticals Inc. published this content on July 08, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on July 08, 2025 at 21:26 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io